119 related articles for article (PubMed ID: 4899417)
21. [Thyrotoxicosis and benzidarone].
Camus JP; Prier A; Kartun P; Mauguélis de Bourguesdon
Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):148-50. PubMed ID: 4705339
[No Abstract] [Full Text] [Related]
22. [Benziodarone in the treatment of gout].
Ryckewaert A; Puel M; Kuntz D
Therapeutique; 1971 Apr; 47(4):371-7. PubMed ID: 5564049
[No Abstract] [Full Text] [Related]
23. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
Mugler A
Rein Foie; 1967; 10():273-92. PubMed ID: 6081455
[No Abstract] [Full Text] [Related]
24. Uricosuric agents.
Fanelli GM
Arthritis Rheum; 1975; 18(6 Suppl):853-8. PubMed ID: 1201130
[No Abstract] [Full Text] [Related]
25. [Uricosuric agents].
Zöllner N; Gröbner W
Arzneimittelforschung; 1971 Oct; 21(10):1500-3. PubMed ID: 5171869
[No Abstract] [Full Text] [Related]
26. [The hypouricemic effect of benziodarone].
Gospodinoff L; Salvini S
Clin Ter; 1969 Oct; 51(2):153-8. PubMed ID: 5365825
[No Abstract] [Full Text] [Related]
27. [Basic therapy of gout by benziodarone].
Ryckewaert A; Kuntz D; Henrard JC; Puel M; de Seze S
Presse Med (1893); 1969 Jul; 77(33):1157-60. PubMed ID: 4978390
[No Abstract] [Full Text] [Related]
28. Uricosuric effect of benziodarone in man and laboratory animals: a comparative study.
Lemieux G; Gougoux A; Vinay P; Michaud G
Am J Physiol; 1973 Jun; 224(6):1431-9. PubMed ID: 4197184
[No Abstract] [Full Text] [Related]
29. [Clinical trial of a new drug "uridion" (author's transl)].
Bazant F
Wien Klin Wochenschr; 1973 Oct; 85(42):697-9. PubMed ID: 4766053
[No Abstract] [Full Text] [Related]
30. [Benzodiarone in the therapy of gout].
Chériè Lignière G; Solazzi F
Reumatismo; 1968; 20(1):53-62. PubMed ID: 5708869
[No Abstract] [Full Text] [Related]
31. [Hyperuricemia and gout; treatment of an acute attack of gout].
Gast LF; Cats A; van Romunde LK
Ned Tijdschr Geneeskd; 1983 Dec; 127(49):2235-7. PubMed ID: 6656915
[No Abstract] [Full Text] [Related]
32. [Benziodarone therapy in hyperuricemia in the aged].
Ravera M; Ugo C
G Gerontol; 1970 Sep; 18(9):876-9. PubMed ID: 5517231
[No Abstract] [Full Text] [Related]
33. [Experience with benziodarone therapy in gout and hyperuricemic syndrome].
Jorda V; Vykydal M; Pegrimová E; Bouvenot G
Beitr Rheumatol; 1972; 18():96-9. PubMed ID: 4649127
[No Abstract] [Full Text] [Related]
34. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
Delbarre F; Saporta L; de Géry A; Jabre E
Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852
[No Abstract] [Full Text] [Related]
35. [On clinical experiences with 2-ethyl-3(4-hydroxy-3,5-dibrombenzoyl)-benzofuran ("Benzbromaron") in the therapy of gout and hyperuricemia].
Kotzaurek R; Hueber EF
Wien Med Wochenschr; 1968 Nov; 118(47):1014-8. PubMed ID: 5704263
[No Abstract] [Full Text] [Related]
36. [Gout: a conquered disease? Evaluation of the treatment of 480 patients with hypouricemic drugs].
Serre H; Simon L; Claustre J
Bull Acad Natl Med; 1971 Jul; 155(23):558-65. PubMed ID: 4942839
[No Abstract] [Full Text] [Related]
37. [Effects of benziodarone on hyperuricemia].
Josef H; Cossermelli W; Debes AC; Kopersztych S
AMB Rev Assoc Med Bras; 1969 Sep; 15(9):381-2. PubMed ID: 5309746
[No Abstract] [Full Text] [Related]
38. [On the hypouricemic and uricuric action of benziodarone].
Taddeucci E; Terreni F
Minerva Med; 1970 Apr; 61(33):1771-6. PubMed ID: 5443241
[No Abstract] [Full Text] [Related]
39. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
[TBL] [Abstract][Full Text] [Related]
40. [Allopurinol (HPP) in the treatment of gout and hyperuricemia due to thiazide diuretics].
Rapado Errazti A
Rev Clin Esp; 1965 Jul; 98(2):133-7. PubMed ID: 5859716
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
